Get started
Author

Dubravka Smiljkovic

Observed name: D. Smiljkovic
ORCID: 0000-0002-4016-4259
Observed ORCID: 0000-0002-4016-4259
OpenAlex ID: A5072747191
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis
2015 · Katharina Blatt, Sabine Cerny-Reiterer, et al. · Blood · 62
BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils
2017 · D. Smiljkovic, K. Blatt, et al. · Allergy · 59
PDF
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
2018 · Mathias Schneeweiss, Barbara Peter, et al. · Haematologica · 37
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils
2022 · Dubravka Smiljkovic, Harald Herrmann, et al. · Journal of Allergy and Clinical Immunology · 30
PDF
Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells
2020 · Nadine Landolina, Ilan Zaffran, et al. · Pharmacological Research · 28
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
2017 · Christian Lupinek, Kurt Derfler, et al. · EBioMedicine · 28
PDF
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
2022 · Peter Valent, Cem Akin, et al. · Journal of Allergy and Clinical Immunology · 27
Cell-based and antibody-mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues
2020 · Peter Valent, Karin Bauer, et al. · Stem Cells Translational Medicine · 22
PDF
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
2019 · Susanne Gamperl, Gabriele Stefanzl, et al. · Veterinary and Comparative Oncology · 18
PDF
Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments
2018 · E. Gadermaier, K. Marth, et al. · Allergy · 17
PDF
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
2023 · Lina Degenfeld-Schonburg, Susanne Gamperl, et al. · PubMed Central · 16
PDF
Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
2019 · N. Najafi, G. Hofer, et al. · Scientific Reports · 14
PDF
Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis
2020 · Dubravka Smiljkovic, Renata Kiss, et al. · The Journal of Allergy and Clinical Immunology In Practice · 12
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils
2024 · Lina Degenfeld-Schonburg, Irina Sadovnik, et al. · Cells · 7
PDF
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia
2022 · Irina Sadovnik, Daniel Ivanov, et al. · Cells · 6
PDF
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis
2021 · Daniela Berger, Karin Bauer, et al. · Neoplasia · 4
Identification of Homing Receptors and Activation-Linked Surface Antigens on Human Mast Cells and Basophils
2026 · Karin Bauer, Dubravka Smiljkovic, et al. · Journal of Investigative Dermatology
1024eTiP LB-208/AOP208 a first-in-class HTR1B antagonist: First-in-human, dose finding phase I study for the evaluation of safety, pharmacokinetics, pharmacodynamics, and anti-tumor activity in adult patients with relapsed or refractory solid tumors or lymphoma
2025 · K.I. Rojas Laimito, G. Molina Lores, et al. · Annals of Oncology
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells
2022 · Mathias Schneeweiss-Gleixner, Yüksel Filik, et al. · Cancers
PDF
Works count: 19
Citation count: 387
H-index: 12
I10-index: 13
Year
Topic
Type